Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients?

Journal of Research in Medical Sciences

Volumn 18, Issue 8, 2013, Pages 653-658

  Behdani, Fatemeh ^a   Hebrani, Paria ^a   Naseraee, Afshin ^a   Haghighi, Mehri Baghban ^a   Akhavanrezayat, Amir ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Attention defcit hyperactivity disorder; Methylphenidate; Omega 3

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; METHYLPHENIDATE; OMEGA 3 FATTY ACID; PLACEBO;

ABDOMINAL PAIN; ADD ON THERAPY; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SUPPLEMENTATION; TEACHER; TREATMENT OUTCOME; VOMITING;

EID: 84884765398     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bussing R. Diagnostic utility of two commonly used ADHD screening measures among special education students. J Am Acad Child Adolesc Psychiatry 1998;37:74-82.
2. Findling RL, Dogin JW. Psychopharmacology of ADHD in children and adolescents. J Clin Psychiatry 1998;59 7:42-49.
3. Silva R, Munoz D, Alpert M. Carbamazepine use in children and Adolescents with features of ADHD, A meta analysis. J Am Acad Child Adolesc Psychiatry 1996;35:352-357.
4. Conners DF, Fletcher KE, Swanson JW. A meta analysis of clonidine for symptoms of ADHD. J Am Acad Child Adolesc Psychiatry 1999;38:1551-1559.
5. Jenson P. ADHD co morbidity fndings from the MTA study: Comparing co morbid subgroups. J Am Acad Child Adolesc Psychiatry 2000;40:147-157.
6. Cormier E. Attention defcit/hyperactivity disorder: A review and update. J Pediatr Nurs 2008;23:345-357.
7. Quintero J, Rodríguez-Quirós J, Correas-Laufer J, Pérez-Templado J. Nutritional aspects of atention-defcit/hyperactive disorder. Rev Neurol 2009;49:307-312.
8. Kalmin S, Launer L, Ot A, Witeman JC, Hofman A, Breteler MM. Dietary fat intake and the risk of incident dementia in the roterdam study. Ann Neurol 1997;42:776-782.
9. Appleton KM, Woodside JV, Yarnell JW, Arveiler D, Haas B, Amouyel P, et al. Depressed mood and dietary fish intake: Direct relationship or indirect relationship as a result of diet and lifestyle? J Afect Disord 2007;104:217-223.
10. Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential faty acid levels in hyperactive children. Clin Pediatr (Phila) 1987;26:406-411.
11. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, et al. Essential faty acid metabolism in boys with attention-defcit hyperactivity disorder. Am J Clin Nutr 1995;62:761-768.
12. Chen JR, Hsu SF, Hsu CD, Hwang LH, Yang SC. Dietary patterns and blood fatty acid composition in children with atention-defcit hyperactivity disorder in Taiwan. J Nutr Biochem 2004;15:467-472.
13. Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, et al. EFA supplementation in children with inatention, hyperactivity, and other disruptive behaviors. Lipids 2003;38:1007-1021.
14. Colter AL, Cutler C, Meckling KA. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: A case-control study. Nutr J 2008;7:8.
15. Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci 2001;16:159-165.
16. Kavanagh T, Lonergan PE, Lynch MA. Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide induced inhibition of long-term potentiation. Prostaglandins Leukot Essent Faty Acids 2004;70:391-397.
17. Sinn N. Physical faty acid defciency signs in children with ADHD symptoms. Prostaglandins Leukot Essent Faty Acids 2007;77:109-115.
18. Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 faty acids in boys with behavior, learning, and health problems. Physiol Behav 1996;59:915-920.
19. Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with atention-defcit/hyperactivity disorder. J Pediatr 2001;139:189-196.
20. Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, et al. Supplementation with fax oil and vitamin C improves the outcome of atention defcit hyperactivity Disorder. Prostaglandins Leukot Essent Faty Acids 2006;74:17-21.
21. Arnold LE, Kleykamp D, Votolato NA, Taylor WA, Kontras SB, Tobin K. Gamma-linolenic acid for atention-defcit hyperactivity disorder: Placebo-controlled comparison to D-amphetamine. Biol Psychiatry 1989;25:222-228.
22. Arnold LE, Kleykamp D, Votolato N, Gibson RA, Horrocks L. Potential link between dietary intake of faty acids and behaviour: Pilot exploration of serum lipids in attention-defcit hyperactivity disorder. J Child Adolesc Psychopharmacol 1994;4:171-182.
23. Hirayama S, Hamazaki T, Terasawa K. Efect of docosahexaenoic acid-containing food administration on symptoms of attention defcit/hyperactivity disorder: A placebo-controlled double-blind study. Eur J Clin Nutr 2004;58:467-473.
24. Vaisman N, Kaysar N, Zaruk-Adasha Y, Pelled D, Brichon G, Zwingelsteint G, et al. Correlation between changes in blood faty acid composition and visual sustained atention performance in children with inattention: Effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr 2008;87:1170-1180.
25. Johnson M, Ostlund S, Fransson G, Kadesjö B, Gillberg C. Omega-3/omega-6 faty acids for atention defcit hyperactivity disorder: A randomized placebo-controlled trial in children and adolescents. J Aten Disord 2009;12:394-401.
26. Raz R, Gabis L. Essential faty acids and atention-defcit-hyperactivity disorder: A systematic review. Dev Med Child Neurol 2009;51:580-592.
27. Gillies D, Sinn JK, Lad SS, Leach MJ, Ross MJ. Polyunsaturated faty acids for atention defcit hyperactivity disorder in children and adolescents. Cochrane Database Syst Rev 2012;7:CD007986.
28. DuPaul G, Power T, Anastopoulos A, Reid R. ADHD Rating Scale-IV. New York: Guilford; 1998.
29. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H. Selegiline in the treatment of attention-deficit hyperactivity disorder in children: A double-blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:841-845.
30. Akhondzadeh S, Mohammadi MR, Khademi M. Zinc sulfate as an adjunct to methylphenidate for the treatment of atention defcit hyperactivity disorder in children: A double blind and randomized trial [ISRCTN64132371]. BMC Psychiatry2004;8:9.
31. Ng KH, Meyer BJ, Reece L, Sinn N. Dietary PUFA intakes in children with atention-defcit/hyperactivity disorder symptoms. Br J Nutr 2009;102:1635-1641.
32. Vancassel S, Blondeau C, Lallemand S, Cador M, Linard A, Lavialle M, et al. Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated faty acids in the frontal cortex. Behav Brain Res 2007;180:119-126.
33. Richardson AJ, Ross MA. Fatty acid metabolism in neuro developmental disorder: A new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Faty Acids 2000;63:1-9.
34. Transler C, Eilander A, Mitchell S, van de Meer N. The impact of polyunsaturated faty acids in reducing child atention defcit and hyperactivity disorders. J Aten Disord 2010;14:232-246.
35. Aben A, Danckaerts M. Omega-3 and omega-6 faty acids in the treatment of children and adolescents with ADHD. Tidschr Psychiatr 2010;52:89-97.
36. Huss M, Völp A, Stauss-Grabo M. Supplementation of polyunsaturated faty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems-an observational cohort study. Lipids Health Dis 2010;9:105.
37. Bélanger SA, Vanasse M, Spahis S, Sylvestre MP, Lippé S, L'heureux F, et al. Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study. Paediatr Child Health 2009;14:89-98.
38. Gustafsson PA, Birberg-Thornberg U, Duchén K, Landgren M, Malmberg K, Pelling H, et al. EPA supplementation improves teacher-rated behavior and oppositional symptoms in children with ADHD. Acta Paediatr 2010;99:1540-1549.
39. Li D, Hu X. Fish and its multiple human health effects in times of threat to sustainability and affordability: Are there alternatives? Asia Pac J Clin Nutr 2009;18:553-563.